Literature DB >> 24550369

Misclassification can explain most apparent regression of age-related macular degeneration: results from multistate models with misclassification.

Ronald E Gangnon1, Kristine E Lee, Barbara E K Klein, Sudha K Iyengar, Theru A Sivakumaran, Ronald Klein.   

Abstract

PURPOSE: To investigate the impact of misclassification of age-related macular degeneration (AMD) on the baseline intensity and estimated effects of age, sex, and the Y402H variant in the complement factor H (CFH) gene on incidence, progression, and regression of AMD.
METHODS: The Beaver Dam Eye Study, a longitudinal population-based study of age-related eye diseases conducted in the city and township of Beaver Dam, Wisconsin, performed examinations every 5 years during a 20-year period (1988-1990 through 2008-2010). Study participants (N = 4379) aged 43 to 86 years at the baseline examination had retinal photographs taken at baseline and up to four subsequent examinations. Multistate models with misclassification in continuous time were used to model the effects of age, sex, and CFH genotype on incidence, progression, and regression of AMD and mortality.
RESULTS: After accounting for AMD misclassification, the occurrence of any AMD regression was rare (1%-4%), while it was relatively common (14%-21%) in models that do not account for misclassification. Failure to account for misclassification attenuated estimated age effects on incidence and progression to moderately severe early AMD and attenuated estimated CFH effects on incidence and progressions to moderately severe and severe early AMD.
CONCLUSIONS: Apparent regression of AMD can largely, if not completely, be explained by misclassification. Estimated age effects on incidence and progression to moderately severe early AMD and estimated CFH effects on incidence and progressions to moderately severe and severe early AMD were attenuated in multistate models that did not account for misclassification.

Entities:  

Keywords:  CFH; age-related macular degeneration; epidemiology

Mesh:

Substances:

Year:  2014        PMID: 24550369      PMCID: PMC3968926          DOI: 10.1167/iovs.13-12375

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  35 in total

Review 1.  Inference for multi-state models from interval-censored data.

Authors:  D Commenges
Journal:  Stat Methods Med Res       Date:  2002-04       Impact factor: 3.021

Review 2.  Multi-state models for event history analysis.

Authors:  Per Kragh Andersen; Niels Keiding
Journal:  Stat Methods Med Res       Date:  2002-04       Impact factor: 3.021

3.  Drusen and disciform macular detachment and degeneration.

Authors:  J D Gass
Journal:  Arch Ophthalmol       Date:  1973-09

4.  Estimating the error rates of diagnostic tests.

Authors:  S L Hui; S D Walter
Journal:  Biometrics       Date:  1980-03       Impact factor: 2.571

5.  Incidence and progression rates of age-related maculopathy: the Rotterdam Study.

Authors:  C C Klaver; J J Assink; R van Leeuwen; R C Wolfs; J R Vingerling; T Stijnen; A Hofman; P T de Jong
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-09       Impact factor: 4.799

6.  Five-year incidence of age-related maculopathy lesions: the Blue Mountains Eye Study.

Authors:  Paul Mitchell; Jie Jin Wang; Suriya Foran; Wayne Smith
Journal:  Ophthalmology       Date:  2002-06       Impact factor: 12.079

7.  Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort.

Authors:  Jie Jin Wang; Suriya Foran; Wayne Smith; Paul Mitchell
Journal:  Arch Ophthalmol       Date:  2003-05

8.  The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study.

Authors:  Redmer van Leeuwen; Caroline C W Klaver; Johannes R Vingerling; Albert Hofman; Paulus T V M de Jong
Journal:  Arch Ophthalmol       Date:  2003-04

9.  Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study.

Authors:  Ronald Klein; Barbara E K Klein; Sandra C Tomany; Stacy M Meuer; Guan-Hua Huang
Journal:  Ophthalmology       Date:  2002-10       Impact factor: 12.079

10.  Incidence of visual impairment over a 20-year period: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Kristine E Lee; Ronald E Gangnon; Barbara E K Klein
Journal:  Ophthalmology       Date:  2013-03-01       Impact factor: 12.079

View more
  3 in total

1.  AMD Genetics: Methods and Analyses for Association, Progression, and Prediction.

Authors:  Qi Yan; Ying Ding; Daniel E Weeks; Wei Chen
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Severity of age-related macular degeneration in 1 eye and the incidence and progression of age-related macular degeneration in the fellow eye: the Beaver Dam Eye Study.

Authors:  Ronald E Gangnon; Kristine E Lee; Barbara E K Klein; Sudha K Iyengar; Theru A Sivakumaran; Ronald Klein
Journal:  JAMA Ophthalmol       Date:  2015-02       Impact factor: 7.389

3.  Assessing type I error and power of multistate Markov models for panel data-A simulation study.

Authors:  Christy Cassarly; Renee' H Martin; Marc Chimowitz; Edsel A Peña; Viswanathan Ramakrishnan; Yuko Y Palesch
Journal:  Commun Stat Simul Comput       Date:  2016-09-23       Impact factor: 1.118

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.